(Q45764433)

15 December 2017

title

Recombinant adeno-associated virus for muscle directed gene therapy (English)

1 reference

15 December 2017

0 references

Fisher KJ

1

1 reference

15 December 2017

Jooss K

2

1 reference

15 December 2017

Alston J

3

1 reference

15 December 2017

Yang Y

4

1 reference

15 December 2017

Haecker SE

5

1 reference

15 December 2017

High K

6

1 reference

15 December 2017

Pathak R

7

1 reference

15 December 2017

Raper SE

8

1 reference

15 December 2017

Wilson JM

9

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

15 December 2017

published in

Nature Medicine

1 reference

15 December 2017

volume

3

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

306-312

1 reference

15 December 2017

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

The responsiveness of a tetracycline-sensitive expression system differs in different cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

A humanized system for pharmacologic control of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

Prospects for the use of adeno-associated virus as a vector for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Site-specific integration by adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Targeted integration of adeno-associated virus (AAV) into human chromosome 19

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Adeno-associated virus vectors preferentially transduce cells in S phase.

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Conserved chromatin structure in c-myc 5'flanking DNA after viral transduction

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Adeno-associated virus general transduction vectors: analysis of proviral structures

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Fluorescence in situ hybridization: applications in cytogenetics and gene mapping

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Systemic delivery of human growth hormone by injection of genetically engineered myoblasts.

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Systemic delivery of recombinant proteins by genetically modified myoblasts

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

A method to codetect introduced genes and their products in gene therapy protocols

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Isolation and analysis of adenovirus type 5 mutants containing deletions in the gene encoding the DNA-binding protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-306

7 January 2021

Identifiers

DOI

10.1038/NM0397-306

1 reference

15 December 2017

Dimensions Publication ID

1037177455

0 references

1 reference

15 December 2017